The initial public offering of Akums Drugs and Pharmaceuticals Ltd. opened for subscription on Tuesday to raise up to Rs 1,856.7 crore and was subscribed 1.37 times.
It is a fresh issue of equity shares worth Rs 680 crore and an offer for sale of 1.73 crore shares by promoters and an existing investor.
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
The pharma major has set a price band of Rs 646–679 per share for its IPO. Sanjeev Jain and Sandeep Jain are the promoters selling 15.1 lakh shares each, while Ruby QC Investment Holdings Pte will offload 1.43 crore shares under the OFS component.
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
The minimum lot size for bidding will be 22 shares, with further bids to be made in multiples. ICICI Securities Ltd, Axis Capital Ltd., Citigroup Global Markets India Pvt. and Ambit Pvt. are the book-running lead managers for the issue.
The company raised Rs 828 crore from anchor investors ahead of its IPO. It allotted 1.22 crore shares at Rs 679 apiece to 50 anchor investors.
Proceeds from the fresh issue will be used to repay debt, fund the working-capital requirements of the company, pursue inorganic-growth initiatives through acquisition, and general corporate purposes.
Issue Details
Issue opens: July 30.
Issue closes: Aug. 1.
Issue price: Rs 646 to Rs 679 per share.
Total issue size: Rs 1,856.7 crore.
Bid lot: 22 shares.
Listing: BSE and NSE.
Business
The contract development and manufacturing organisation offers a comprehensive range of pharmaceutical products and services in India and overseas. It owns the intellectual property for the manufacturing processes of several formulations, and their core business is focused on providing end-to-end product development and manufacturing solutions to clients.
Some of their other services include formulation research and development, preparation and filing of regulatory dossiers in the Indian and global markets. The company is also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients.
Subscription Status: Day 1
The IPO has been subscribed 1.37 times as of 5 p.m. on Tuesday.
Institutional investors: 0.43 times, or 43%.
Non-institutional investors: 1.96 times.
Retail investors: 3.35 times.
Employee reserved: 1.07 times.
Watch IPO Adda Here:
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
